table of content
1 Introduction to Research & Analysis Reports
1.1 Hereditary Cancer Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hereditary Cancer Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hereditary Cancer Testing Overall Market Size
2.1 Global Hereditary Cancer Testing Market Size: 2021 VS 2028
2.2 Global Hereditary Cancer Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hereditary Cancer Testing Players in Global Market
3.2 Top Global Hereditary Cancer Testing Companies Ranked by Revenue
3.3 Global Hereditary Cancer Testing Revenue by Companies
3.4 Top 3 and Top 5 Hereditary Cancer Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hereditary Cancer Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hereditary Cancer Testing Players in Global Market
3.6.1 List of Global Tier 1 Hereditary Cancer Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Hereditary Cancer Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Hereditary Cancer Testing Market Size Markets, 2021 & 2028
4.1.2 RNA Testing
4.1.3 DNA Testing
4.2 By Type - Global Hereditary Cancer Testing Revenue & Forecasts
4.2.1 By Type - Global Hereditary Cancer Testing Revenue, 2017-2022
4.2.2 By Type - Global Hereditary Cancer Testing Revenue, 2023-2028
4.2.3 By Type - Global Hereditary Cancer Testing Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hereditary Cancer Testing Market Size, 2021 & 2028
5.1.2 Breast Cancer
5.1.3 Gastrointestinal Cancer
5.1.4 Prostate Cancer
5.1.5 Respiratory/Lung Cancer
5.1.6 Other Cancers
5.2 By Application - Global Hereditary Cancer Testing Revenue & Forecasts
5.2.1 By Application - Global Hereditary Cancer Testing Revenue, 2017-2022
5.2.2 By Application - Global Hereditary Cancer Testing Revenue, 2023-2028
5.2.3 By Application - Global Hereditary Cancer Testing Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Hereditary Cancer Testing Market Size, 2021 & 2028
6.2 By Region - Global Hereditary Cancer Testing Revenue & Forecasts
6.2.1 By Region - Global Hereditary Cancer Testing Revenue, 2017-2022
6.2.2 By Region - Global Hereditary Cancer Testing Revenue, 2023-2028
6.2.3 By Region - Global Hereditary Cancer Testing Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Hereditary Cancer Testing Revenue, 2017-2028
6.3.2 US Hereditary Cancer Testing Market Size, 2017-2028
6.3.3 Canada Hereditary Cancer Testing Market Size, 2017-2028
6.3.4 Mexico Hereditary Cancer Testing Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Hereditary Cancer Testing Revenue, 2017-2028
6.4.2 Germany Hereditary Cancer Testing Market Size, 2017-2028
6.4.3 France Hereditary Cancer Testing Market Size, 2017-2028
6.4.4 U.K. Hereditary Cancer Testing Market Size, 2017-2028
6.4.5 Italy Hereditary Cancer Testing Market Size, 2017-2028
6.4.6 Russia Hereditary Cancer Testing Market Size, 2017-2028
6.4.7 Nordic Countries Hereditary Cancer Testing Market Size, 2017-2028
6.4.8 Benelux Hereditary Cancer Testing Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Hereditary Cancer Testing Revenue, 2017-2028
6.5.2 China Hereditary Cancer Testing Market Size, 2017-2028
6.5.3 Japan Hereditary Cancer Testing Market Size, 2017-2028
6.5.4 South Korea Hereditary Cancer Testing Market Size, 2017-2028
6.5.5 Southeast Asia Hereditary Cancer Testing Market Size, 2017-2028
6.5.6 India Hereditary Cancer Testing Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Hereditary Cancer Testing Revenue, 2017-2028
6.6.2 Brazil Hereditary Cancer Testing Market Size, 2017-2028
6.6.3 Argentina Hereditary Cancer Testing Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hereditary Cancer Testing Revenue, 2017-2028
6.7.2 Turkey Hereditary Cancer Testing Market Size, 2017-2028
6.7.3 Israel Hereditary Cancer Testing Market Size, 2017-2028
6.7.4 Saudi Arabia Hereditary Cancer Testing Market Size, 2017-2028
6.7.5 UAE Hereditary Cancer Testing Market Size, 2017-2028
7 Players Profiles
7.1 Ambry Genetics (Konica Minota)
7.1.1 Ambry Genetics (Konica Minota) Corporate Summary
7.1.2 Ambry Genetics (Konica Minota) Business Overview
7.1.3 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Major Product Offerings
7.1.4 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.1.5 Ambry Genetics (Konica Minota) Key News
7.2 Asper Biogene
7.2.1 Asper Biogene Corporate Summary
7.2.2 Asper Biogene Business Overview
7.2.3 Asper Biogene Hereditary Cancer Testing Major Product Offerings
7.2.4 Asper Biogene Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.2.5 Asper Biogene Key News
7.3 Natera
7.3.1 Natera Corporate Summary
7.3.2 Natera Business Overview
7.3.3 Natera Hereditary Cancer Testing Major Product Offerings
7.3.4 Natera Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.3.5 Natera Key News
7.4 Caris Life Sciences
7.4.1 Caris Life Sciences Corporate Summary
7.4.2 Caris Life Sciences Business Overview
7.4.3 Caris Life Sciences Hereditary Cancer Testing Major Product Offerings
7.4.4 Caris Life Sciences Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.4.5 Caris Life Sciences Key News
7.5 BioReference Laboratories (GeneDx)
7.5.1 BioReference Laboratories (GeneDx) Corporate Summary
7.5.2 BioReference Laboratories (GeneDx) Business Overview
7.5.3 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Major Product Offerings
7.5.4 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.5.5 BioReference Laboratories (GeneDx) Key News
7.6 LabSolutions
7.6.1 LabSolutions Corporate Summary
7.6.2 LabSolutions Business Overview
7.6.3 LabSolutions Hereditary Cancer Testing Major Product Offerings
7.6.4 LabSolutions Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.6.5 LabSolutions Key News
7.7 Progenity?Inc
7.7.1 Progenity?Inc Corporate Summary
7.7.2 Progenity?Inc Business Overview
7.7.3 Progenity?Inc Hereditary Cancer Testing Major Product Offerings
7.7.4 Progenity?Inc Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.7.5 Progenity?Inc Key News
7.8 ARUP Laboratories
7.8.1 ARUP Laboratories Corporate Summary
7.8.2 ARUP Laboratories Business Overview
7.8.3 ARUP Laboratories Hereditary Cancer Testing Major Product Offerings
7.8.4 ARUP Laboratories Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.8.5 ARUP Laboratories Key News
7.9 Myriad
7.9.1 Myriad Corporate Summary
7.9.2 Myriad Business Overview
7.9.3 Myriad Hereditary Cancer Testing Major Product Offerings
7.9.4 Myriad Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.9.5 Myriad Key News
7.10 NeoGenomics
7.10.1 NeoGenomics Corporate Summary
7.10.2 NeoGenomics Business Overview
7.10.3 NeoGenomics Hereditary Cancer Testing Major Product Offerings
7.10.4 NeoGenomics Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.10.5 NeoGenomics Key News
7.11 Blueprint Genetics
7.11.1 Blueprint Genetics Corporate Summary
7.11.2 Blueprint Genetics Business Overview
7.11.3 Blueprint Genetics Hereditary Cancer Testing Major Product Offerings
7.11.4 Blueprint Genetics Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.11.5 Blueprint Genetics Key News
7.12 CellMax Life
7.12.1 CellMax Life Corporate Summary
7.12.2 CellMax Life Business Overview
7.12.3 CellMax Life Hereditary Cancer Testing Major Product Offerings
7.12.4 CellMax Life Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.12.5 CellMax Life Key News
7.13 Fulgent Genetics
7.13.1 Fulgent Genetics Corporate Summary
7.13.2 Fulgent Genetics Business Overview
7.13.3 Fulgent Genetics Hereditary Cancer Testing Major Product Offerings
7.13.4 Fulgent Genetics Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.13.5 Fulgent Genetics Key News
7.14 Strand Life Sciences
7.14.1 Strand Life Sciences Corporate Summary
7.14.2 Strand Life Sciences Business Overview
7.14.3 Strand Life Sciences Hereditary Cancer Testing Major Product Offerings
7.14.4 Strand Life Sciences Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.14.5 Strand Life Sciences Key News
7.15 Myogenes
7.15.1 Myogenes Corporate Summary
7.15.2 Myogenes Business Overview
7.15.3 Myogenes Hereditary Cancer Testing Major Product Offerings
7.15.4 Myogenes Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.15.5 Myogenes Key News
7.16 LabCorp
7.16.1 LabCorp Corporate Summary
7.16.2 LabCorp Business Overview
7.16.3 LabCorp Hereditary Cancer Testing Major Product Offerings
7.16.4 LabCorp Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.16.5 LabCorp Key News
7.17 Quest Diagnostics
7.17.1 Quest Diagnostics Corporate Summary
7.17.2 Quest Diagnostics Business Overview
7.17.3 Quest Diagnostics Hereditary Cancer Testing Major Product Offerings
7.17.4 Quest Diagnostics Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.17.5 Quest Diagnostics Key News
7.18 Pathway Genomics
7.18.1 Pathway Genomics Corporate Summary
7.18.2 Pathway Genomics Business Overview
7.18.3 Pathway Genomics Hereditary Cancer Testing Major Product Offerings
7.18.4 Pathway Genomics Hereditary Cancer Testing Revenue in Global Market (2017-2022)
7.18.5 Pathway Genomics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
